According to the Zhitong Finance APP, LBPMedicin (688393.SH) released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 471 million yuan, a year-on-year decrease of 5.33%; the net profit attributable to shareholders of the listed company was 22.0369 million yuan, a year-on-year decrease of 44.99%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 13.7024 million yuan, a year-on-year decrease of 61.20%; basic earnings per share were 0.24 yuan/share